Pure Encapsulations - CurcumaSorb - with Meriva Bioavailable Curcumin Phytosome - 180 Capsules
|
상품가격 상세보기
이벤트보기
|
- 상품상세정보
상품특징
Enhanced Absorption: CurcumaSorb provides the patented Meriva curcumin-phosphatidylcholine complex for enhanced absorption and bioavailability.Joint Support: A low dose was demonstrated in a three-month clinical trial, in which 200 mg curcuminoids from Meriva per day provided significant benefit in joint comfort, mobility and quality of life.*Overall Health: Provides support for musculoskeletal, digestive, liver, brain, cellular and cardiovascular health.*Pure Ingredients: Pure Encapsulations manufactures a line of hypoallergenic, research-based dietary supplements. Products are meticulously formulated using pure ingredients designed to deliver predictable results for the benefit of all patients, even the most sensitive.*Free From: Pure Encapsulations products are free from wheat, gluten, egg, peanuts, magnesium stearate, hydrogenated fat, artificial sweeteners and colors, and other unnecessary excipients. Any product containing ingredients derived from allergens, such as soy, dairy or shellfish is clearly labeled. *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
상품설명
Product Packaging:Standard Packaging CurcumaSorb provides the patented Meriva curcumin-phosphatidylcholine complex for enhanced absorption and bioavailability. The proprietary phytosome technology combines curcumin and phosphatidylcholine at a 1:2 ratio promoting resistance to degradation in the digestive tract and efficient absorption across membranes. This produces significantly higher peak plasma concentrations and larger area under concentration-time curves (AUC). In a single-dose pharmacokinetic animal study, plasma curcumin levels were 20-fold greater with Meriva than standard curcumin. A preliminary human pharmacokinetic study demonstrated that elevations in plasma curcumin from 450 mg. Meriva were similar to values obtained from 4,000 mg. of a standard curcumin extract. The efficacy of a low dose was demonstrated in a 3-month clinical trial, in which 200 mg. curcuminoids from Meriva per day maintained healthy C-reactive protein levels and provided significant benefit in joint comfort, mobility and quality of life.*
Enhanced Absorption: CurcumaSorb provides the patented Meriva curcumin-phosphatidylcholine complex for enhanced absorption and bioavailability.Joint Support: A low dose was demonstrated in a three-month clinical trial, in which 200 mg curcuminoids from Meriva per day provided significant benefit in joint comfort, mobility and quality of life.*Overall Health: Provides support for musculoskeletal, digestive, liver, brain, cellular and cardiovascular health.*Pure Ingredients: Pure Encapsulations manufactures a line of hypoallergenic, research-based dietary supplements. Products are meticulously formulated using pure ingredients designed to deliver predictable results for the benefit of all patients, even the most sensitive.*Free From: Pure Encapsulations products are free from wheat, gluten, egg, peanuts, magnesium stearate, hydrogenated fat, artificial sweeteners and colors, and other unnecessary excipients. Any product containing ingredients derived from allergens, such as soy, dairy or shellfish is clearly labeled. *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
상품설명
Product Packaging:Standard Packaging CurcumaSorb provides the patented Meriva curcumin-phosphatidylcholine complex for enhanced absorption and bioavailability. The proprietary phytosome technology combines curcumin and phosphatidylcholine at a 1:2 ratio promoting resistance to degradation in the digestive tract and efficient absorption across membranes. This produces significantly higher peak plasma concentrations and larger area under concentration-time curves (AUC). In a single-dose pharmacokinetic animal study, plasma curcumin levels were 20-fold greater with Meriva than standard curcumin. A preliminary human pharmacokinetic study demonstrated that elevations in plasma curcumin from 450 mg. Meriva were similar to values obtained from 4,000 mg. of a standard curcumin extract. The efficacy of a low dose was demonstrated in a 3-month clinical trial, in which 200 mg. curcuminoids from Meriva per day maintained healthy C-reactive protein levels and provided significant benefit in joint comfort, mobility and quality of life.*
2020-05-21 17:46:22